Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Liabilities (2022 - 2025)

Historic Total Liabilities for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $12.3 million.

  • PAVmed's Total Liabilities changed N/A to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year change of. This contributed to the annual value of $37.7 million for FY2024, which is 3403.05% down from last year.
  • Per PAVmed's latest filing, its Total Liabilities stood at $12.3 million for Q3 2025.
  • In the past 5 years, PAVmed's Total Liabilities registered a high of $58.1 million during Q2 2024, and its lowest value of $11.9 million during Q1 2025.
  • Moreover, its 4-year median value for Total Liabilities was $43.0 million (2022), whereas its average is $38.5 million.
  • Per our database at Business Quant, PAVmed's Total Liabilities skyrocketed by 17795.52% in 2023 and then tumbled by 7943.77% in 2025.
  • PAVmed's Total Liabilities (Quarter) stood at $43.0 million in 2022, then surged by 32.73% to $57.1 million in 2023, then plummeted by 34.03% to $37.7 million in 2024, then crashed by 67.42% to $12.3 million in 2025.
  • Its Total Liabilities was $12.3 million in Q3 2025, compared to $12.5 million in Q2 2025 and $11.9 million in Q1 2025.